Timing of Tracheostomy in COVID-19 - Impact on Mortality

How Timing of Tracheostomy in COVID-19 Patients Changed and Its Impact on Mortality

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05175859

Enrollment

117

Registered

2022-01-04

Start date

2020-04-01

Completion date

2021-12-25

Last updated

2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tracheostomy

Brief summary

How timing of tracheostomy in COVID-19 patients changed and its impact on mortality in patients with severe COVID-19 ARDS

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

\- Severe COVID-19 infection requiring endotracheal intubation and prolonged invasive ventilation as part of the treatment of severe to moderate acute respiratory distress syndrome.

Exclusion criteria

* COVID-19 disease, without the need for endotracheal ventilation. * COVID-19 disease with need for endotracheal intubation with anticipated short-term invasive ventilation.

Design outcomes

Primary

Measure	Time frame	Description
Mortality	During intensive care treatment (Usually within 8 weeks)	Deaths in the course of treatment

Countries

Germany

Outcome results